Global Penehyclidine Hydrochloride Market Research Report 2016 by Application, Revenue, Share, Outlook, Development Trends and Analysis to 2021


Global Penehyclidine Hydrochloride Market Segment, Types, Price, Market Share and Growth, focuses on top players in these regions/countries, Size, Demand, Application, Revenue, Share, Outlook,  Development Trends and Analysis  to 2021

This report provides detailed analysis of worldwide markets for Penehyclidine Hydrochloride from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Penehyclidine Hydrochloride market and further lays out an analysis of the factors influencing the supply/demand for Penehyclidine Hydrochloride, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Ask for Sample Report:

Penehyclidine hydrochloride (PHC), a new anticholinergic drug, was invented by the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences in China. Its structure is 3-(2-hydroxyl-2-cyclopentyl-2-phenyl-ethoxy) quinuclidine. PHC was commonly applied in clinics as an antagonist of organic phosphorus poisoning and an anaesthetic premedication at present. Animal studies showed that PHC has anti-inflammatory and antioxidant effects on various organs. It is reported that PHC could improve liver function during cardiopulmonary bypass (CPB). The findings confirmed significant protection by PHC against lipopolysaccharide (LPS)-induced lung vascular leak and inflammation in the management of acute lung injury (ALI). In addition, it has been shown that PHC could alleviate lung injuries by inhibiting apoptosis of lung tissue cells. Recently, several studies demonstrated that PHC could improve PaO2/FiO2, decrease pulmonary microvascular permeability, IL-6 levels and MPO activity through the inhibition of extracellular signal-regulated kinase (ERK1/2) and p38 MAPK activation in septic mice.

GCC’s report, Global Penehyclidine Hydrochloride Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Penehyclidine Hydrochloride market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Penehyclidine Hydrochloride market areChengdu List Pharmaceutical.

Access Full Report At:

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Penehyclidine Hydrochloride industry has been provided.
Table of Contents
Part 1. Scope of Report
1.1 Research Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Key Findings
2.2 Value Chain Analysis
2.2.2 Upstream
2.2.3 Downstream

Part 3. Manufacture
3.1 Manufacturing Process
3.2 Issues and Trends

About Fior Markets

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us

Mark Stone

Sales Manager

Phone: (201) 465-4211



Leave a Reply

Designed by
Powered by